Related Experiment Video
Updated: Jun 28, 2026

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
Published on: March 17, 2023
Physiological consequences of the TRalpha1 aporeceptor state
Jens Mittag1, Karin Wallis, Björn Vennström
1Department of Cell & Molecular Biology, Karolinska Institute, von Eulers väg 3, 17177 Stockholm, Sweden. jens.mittag@ki.se
Mutations in thyroid hormone receptor alpha 1 (TRalpha1) are rare in patients. Animal models reveal variable phenotypes, offering insights into potential human TRalpha1 mutation consequences.
Area of Science:
- Endocrinology
- Molecular Biology
- Genetics
Background:
- Thyroid hormone receptors (TRs) are crucial for development and metabolism.
- Mutations in TRbeta are well-documented in patients with thyroid hormone resistance.
- TRalpha1 mutations have not been identified in human patients, hindering clinical understanding.
Purpose of the Study:
- To review the consequences of TRalpha1 mutations in animal models.
- To identify potential phenotypic characteristics of patients with TRalpha1 mutations.
- To focus on the TRalpha1-R384C mutation and its implications.
Main Methods:
- Review of existing literature on TRalpha1 mutant animal models.
- Analysis of phenotypic data from TRalpha1 mutant mice.
- Comparison of findings across different TRalpha1 mutations.
Main Results:
- TRalpha1 mutant mice exhibit some conserved phenotypes, like adult euthyroidism.
- Metabolic and other phenotypic aspects show significant variability among TRalpha1 mutant models.
- The TRalpha1-R384C mutation serves as a key example for discussion.
Conclusions:
- Animal models are essential for studying the effects of TRalpha1 mutations.
- Insights from mouse models can predict potential human TRalpha1 mutation phenotypes.
- Further research is needed to identify and characterize human TRalpha1 mutations.
Related Concept Videos
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Sympathetic Signaling
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Receptors (Adrenoceptors): Classification
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's phenomenon, is a...
